The meeting, organised by  the SCI's Fine Chemicals Group and the RSC's Biological and Medicinal Chemistry Sector, is focussed on current trends in medicinal chemistry and pharmaceutical research. The scientific programme will feature lectures on a range of drug targets, key enabling processes and technologies, and will include a talk by Selcia’s Director of Drug Discovery entitled “Discovery of Potent Cyclophilin Inhibitors Based on Structural Simplification of Sanglifehrin A”.

For more information visit the SCI website